REVIEW
|
doi:10.20944/preprints202306.1670.v1
Subject:
Medicine And Pharmacology,
Pathology And Pathobiology
Keywords:
HER2 expression; Breast cancer; Neoadjuvant treatment; HER2-low carcinomas; HER2 ultra-low carcinomas
Online: 23 June 2023 (11:55:10 CEST)
REVIEW
|
doi:10.20944/preprints202312.0982.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
HER2; HER2 discovery; HER2 role in cancers; HER 2 low; HER2DX; prognostic; predictive; biomarker; anti-HER therapies; HER2 landmark trials
Online: 13 December 2023 (11:35:40 CET)
REVIEW
|
doi:10.20944/preprints202206.0160.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
breast cancer; HER2-positive; estrogen receptor positive; triple-positive; HER2-targeted therapy; immunotherapy
Online: 10 June 2022 (11:03:05 CEST)
ARTICLE
|
doi:10.20944/preprints202205.0120.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
HER2; PD-1/PD-L1; Mathematical model; HER2/PD-1 Interaction; Breast cancer
Online: 9 May 2022 (14:06:20 CEST)
ARTICLE
|
doi:10.20944/preprints202310.0795.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
HER2; colorectal cancer; immune cell
Online: 13 October 2023 (07:08:38 CEST)
ARTICLE
|
doi:10.20944/preprints201812.0017.v1
Subject:
Medicine And Pharmacology,
Pathology And Pathobiology
Keywords:
primary brain tumor; HER2; immunohistochemistry
Online: 3 December 2018 (09:24:06 CET)
REVIEW
|
doi:10.20944/preprints201902.0043.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
ADC; HM2-MMAE; (vic-)trastuzumab duocarmazine; Trastuzumab deruxtecan; TAK-522; Trastuzumab emtansine; anti-HER2/PBD-MA; HER2 low; HER2-low; mode of action
Online: 4 February 2019 (17:01:31 CET)
ARTICLE
|
doi:10.20944/preprints202112.0441.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
HER2; neoadjuvant; pathologic complete response; trastuzumab
Online: 28 December 2021 (09:58:26 CET)
REVIEW
|
doi:10.20944/preprints202406.0515.v1
Subject:
Biology And Life Sciences,
Cell And Developmental Biology
Keywords:
HER2; Cancer; Metastasis; Immune regulation; ADC; therapeutics
Online: 7 June 2024 (14:59:05 CEST)
COMMUNICATION
|
doi:10.20944/preprints202402.1423.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
HER2+ breast cancer, monoclonal antibodies, trastuzumab biosimilars.
Online: 26 February 2024 (10:20:30 CET)
ARTICLE
|
doi:10.20944/preprints202307.0900.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
HER2; monoclonal antibody; ADCC; CDC; antitumor activity
Online: 13 July 2023 (09:23:17 CEST)
ARTICLE
|
doi:10.20944/preprints202210.0050.v1
Subject:
Medicine And Pharmacology,
Pharmacology And Toxicology
Keywords:
radionuclide; HER2; DARPin; SPECT; 99mTc; imaging; cancer
Online: 6 October 2022 (08:09:37 CEST)
ARTICLE
|
doi:10.20944/preprints201701.0098.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Flavokawain A; HER2 overexpression; resistance to apoptosis
Online: 23 January 2017 (03:30:01 CET)
ARTICLE
|
doi:10.20944/preprints202301.0005.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
HER2; breast cancer; NEDD9 adaptor protein; hyperplasia; AURKA
Online: 3 January 2023 (06:57:38 CET)
ARTICLE
|
doi:10.20944/preprints202210.0028.v1
Subject:
Biology And Life Sciences,
Immunology And Microbiology
Keywords:
EGFR; HER2; bispecific antibody; ADCC; CDC; canine osteosarcoma
Online: 5 October 2022 (09:45:16 CEST)
ARTICLE
|
doi:10.20944/preprints202207.0371.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
biosymilars; metastatic breast cancer; trastuzumab; cost; her2; PTH
Online: 25 July 2022 (10:05:29 CEST)
REVIEW
|
doi:10.20944/preprints202405.2073.v1
Subject:
Medicine And Pharmacology,
Cardiac And Cardiovascular Systems
Keywords:
trastuzumab; LV ejection fraction (LVef); immune-mediated; her2; cardiotoxicity
Online: 31 May 2024 (09:12:22 CEST)
ARTICLE
|
doi:10.20944/preprints202309.0906.v5
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
HER2; cancer-specific monoclonal antibody; screening; epitope; flow cytometry
Online: 4 January 2024 (11:30:55 CET)
REVIEW
|
doi:10.20944/preprints202404.1295.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
HER2; breast cancer; diagnostics; molecular imaging; Affibody molecules; clinical trials
Online: 19 April 2024 (15:08:53 CEST)
ARTICLE
|
doi:10.20944/preprints202402.1136.v1
Subject:
Biology And Life Sciences,
Biology And Biotechnology
Keywords:
Breast carcinoma, Intratumoral heterogeneity, HER2 gene expression, Prognosis, Breast Neoplasms
Online: 20 February 2024 (14:26:43 CET)
COMMUNICATION
|
doi:10.20944/preprints202307.0721.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
mouse HER2; monoclonal antibody; cell-based Immunization and screening; CBIS
Online: 12 July 2023 (03:20:12 CEST)
ARTICLE
|
doi:10.20944/preprints202306.0676.v1
Subject:
Physical Sciences,
Biophysics
Keywords:
Trastuzumab; Pertuzumab; HER2; Binding Free Energy; PRODIGY; Size Exclusion Chromatography
Online: 9 June 2023 (07:01:32 CEST)
ARTICLE
|
doi:10.20944/preprints202304.0002.v1
Subject:
Biology And Life Sciences,
Biochemistry And Molecular Biology
Keywords:
trastuzumab; trastuzumab resistance; HER2; breast cancer; proteomic analysis; metabolic reprogramming.
Online: 3 April 2023 (02:19:25 CEST)
ARTICLE
|
doi:10.20944/preprints202009.0734.v1
Subject:
Biology And Life Sciences,
Anatomy And Physiology
Keywords:
AE36 HER2/neu-derived peptide; Nanoliposomes; CpG-ODN; Vaccine; Cancer
Online: 30 September 2020 (10:12:34 CEST)
COMMUNICATION
|
doi:10.20944/preprints202409.0382.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
salivary gland cancer; HER2; trastuzumab; TDM1; ado-trastuzumab emtansine; trastuzumab deruxtecan
Online: 4 September 2024 (16:05:04 CEST)
REVIEW
|
doi:10.20944/preprints202309.1363.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Breast Cancer; Malignancy; Gulf Cooperation Council(GCC); Survival; HER2; Triple Negative
Online: 20 September 2023 (13:51:45 CEST)
ARTICLE
|
doi:10.20944/preprints202211.0188.v1
Subject:
Medicine And Pharmacology,
Pharmacology And Toxicology
Keywords:
radionuclide molecular imaging; HER2; scaffold proteins; DARPin; ADAPT6; technetium-99m; preclinical
Online: 10 November 2022 (03:31:20 CET)
ARTICLE
|
doi:10.20944/preprints202201.0164.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
breast cancer,; neoadjuvant chemotherapy; elederly; HER2- positive; pathological complete response; safety
Online: 12 January 2022 (13:31:16 CET)
REVIEW
|
doi:10.20944/preprints202401.0437.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
HER2 positive; Breast Cancer; Systemic De-Escalation; Chemo-free therapy; Targeted Therapy
Online: 5 January 2024 (06:47:05 CET)
REVIEW
|
doi:10.20944/preprints202310.1483.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
AR; TNBC; CDK4/6; CYP17 lyase; PI3K/AKT; ER; PR; HER2; DHT
Online: 24 October 2023 (05:51:15 CEST)
ARTICLE
|
doi:10.20944/preprints202407.0666.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
metastatic colorectal cancer; primary tumour localization; anti EGFR therapy; KRAS status; HER2 expression
Online: 9 July 2024 (08:14:29 CEST)
ARTICLE
|
doi:10.20944/preprints202102.0545.v1
Subject:
Biology And Life Sciences,
Biochemistry And Molecular Biology
Keywords:
trastuzumab, HER2, extracellular vesicles, breast cancer, proteomic analysis, immunoelectron microscopy, TOP1, CD63, mitochondria.
Online: 24 February 2021 (11:38:41 CET)
REVIEW
|
doi:10.20944/preprints202311.1632.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
checkpoint inhibitors; esophageal cancer; gastric cancer; immunotherapy; PD-L1; HER2; clinical trials; history; disparities
Online: 28 November 2023 (01:45:08 CET)
ARTICLE
|
doi:10.20944/preprints202307.0169.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
HER2; breast cancer; monoclonal antibody; antitumor activities; mouse xenograft model; antibody-dependent cellular cytotoxicity
Online: 4 July 2023 (09:38:15 CEST)
REVIEW
|
doi:10.20944/preprints202409.0327.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Breast cancer; HER2; Trastuzumab; Pertuzumab; De-escalation; Personalized medicine; Targeted therapies; Adjuvant therapies; Neoadjuvant therapies
Online: 5 September 2024 (04:54:49 CEST)
ARTICLE
|
doi:10.20944/preprints202407.0864.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
HER2; cancer-specific monoclonal antibody; antitumor effect; complement-dependent cellular cytotoxicity
Online: 11 July 2024 (05:20:18 CEST)
CASE REPORT
|
doi:10.20944/preprints202306.1950.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
inflammatory breast carcinoma; targeted biological therapy; HER2 overexpression; multidisciplinary treatment; aggressive cancer management; systemic chemotherapy
Online: 28 June 2023 (07:12:56 CEST)
ARTICLE
|
doi:10.20944/preprints202306.1178.v1
Subject:
Medicine And Pharmacology,
Pathology And Pathobiology
Keywords:
gastric cancer; molecular classification; EBER; MMR; E-cadherin; beta-catenin; p53; Her2; PD-L1; Claudin18.2
Online: 16 June 2023 (05:46:59 CEST)
REVIEW
|
doi:10.20944/preprints202306.0507.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
breast cancer; TILs; PD-L1; immunotherapy; chemotherapy, triple negative breast cancer; HER2; luminal breast cancer; CPS
Online: 7 June 2023 (08:04:20 CEST)
ARTICLE
|
doi:10.20944/preprints201710.0187.v1
Subject:
Computer Science And Mathematics,
Analysis
Keywords:
medical image classification; local binary patterns; characteristic curves; whole slide image pro-cessing; automated HER2 scoring
Online: 31 October 2017 (03:10:22 CET)
REVIEW
|
doi:10.20944/preprints202306.0932.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
gastric cancer; HER2; immunotherapy; PD-1/PD-L1; antibody-drug conjugate; chemotherapy; trastuzumab; novel therapies; clinical trials
Online: 13 June 2023 (11:15:24 CEST)
ARTICLE
|
doi:10.20944/preprints202408.0128.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
HR+/HER2- metastatic breast cancer; HR-positive; Selective estrogen receptor degrader (SERD); Elacestrant; Alpelisib; Precision oncology; Cancer genomics
Online: 2 August 2024 (03:52:29 CEST)
REVIEW
|
doi:10.20944/preprints202304.0736.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
advanced breast cancer; germline BRCA1/2 mutations; pathogenic/likely pathogenic variants; CDK4/6 inhibitors; Pi3Ka inhibitors; HER2-low
Online: 23 April 2023 (03:12:48 CEST)
REVIEW
|
doi:10.20944/preprints202401.0676.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
HER2; breast cancer; breast neoplasms; antibody-drug conjugate; ADCs; trastuzumab emtansine; trastuzumab deruxtecan; disitamab Vedotin; ARX-788; SYD985; BL-M0701; zanidatamab zovodotin.
Online: 9 January 2024 (10:29:59 CET)